Who
David P. King
Director
Company insider
Files Form 4 as: Director, Illumina; Director, Privia Health Group; Director, ZimVie; President & CEO, Labcorp Holdings; Director, Cardinal Health.
In numbers
- Trades disclosed
- 379
- Buys
- 0
- Sells
- 36
- Bought
- $0
- Sold
- $165.1M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 12 Jan 2006
- Last trade
- 21 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 22 May 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | $300K2,072 at $144.83 | filing |
| 21 May 2026filed 22 May 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | $300K2,072 at $144.83 | filing |
| 20 May 2026filed 22 May 2026 | PRVA Privia Health GroupProviders & Facilities | SEC FORM 4 Code A | —8,463 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | PRVA Privia Health GroupProviders & Facilities | SEC FORM 4 Code A | —8,463 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | PRVA Privia Health GroupProviders & Facilities | SEC FORM 4 Code A | —8,396 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ZimVieoption or derivative | SEC FORM 4 Code A | —3,710.58 at $0.00 | filing |
| 31 Dec 2024filed 3 Jan 2025 | ZimVieoption or derivative | SEC FORM 4 Code A | —2,855.1 at $0.00 | filing |
| 30 Sep 2024filed 2 Oct 2024 | ZimVieoption or derivative | SEC FORM 4 Code A | —2,536.46 at $0.00 | filing |
| 30 Jun 2024filed 2 Jul 2024 | ZimVieoption or derivative | SEC FORM 4 Code A | —2,223.46 at $0.00 | filing |
| 22 May 2024filed 23 May 2024 | PRVA Privia Health GroupProviders & Facilities | SEC FORM 4 Code A | —11,124 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | ZimVieoption or derivative | SEC FORM 4 Code A | —500 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | ZimVieoption or derivative | SEC FORM 4 Code A | —14,882 at $0.00 | filing |
| 31 Mar 2024filed 2 Apr 2024 | ZimVieoption or derivative | SEC FORM 4 Code A | —2,437.54 at $0.00 | filing |
| 31 Dec 2023filed 3 Jan 2024 | ZimVieoption or derivative | SEC FORM 4 Code A | —2,150.39 at $0.00 | filing |
| 30 Sep 2023filed 3 Oct 2023 | ZimVieoption or derivative | SEC FORM 4 Code A | —4,117.96 at $0.00 | filing |
| 1 Jul 2023filed 5 Jul 2023 | PRVA Privia Health GroupProviders & Facilities | SEC FORM 4 Code A | —7,758 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | ZimVieoption or derivative | SEC FORM 4 Code A | —3,378.38 at $0.00 | filing |
| 12 May 2023filed 16 May 2023 | ZimVieoption or derivative | SEC FORM 4 Code A | —500 at $0.00 | filing |
| 12 May 2023filed 16 May 2023 | ZimVieoption or derivative | SEC FORM 4 Code A | —23,925 at $0.00 | filing |
| 31 Mar 2023filed 4 Apr 2023 | ZimVieoption or derivative | SEC FORM 4 Code A | —5,496.45 at $0.00 | filing |
News
Cardinal Health Procedure Kits May Contain Recalled BD Alaris Infusion Sets Linked to Over- and Under-Infusion RisksCAH · medicaldaily.com · 22 Oct 2026Labcorp Holdings Inc. (NYSE:LH) Shares to Pay Quarterly Dividend of $0.72LH · dailypolitical.com · 21 Oct 2026Cardinal Health, Stock Of The Day, Nears New Buy Point As Indicators Suggest More UpsideCAH · investors.com · 21 Oct 2026FDA Early Alert Issued After Cardinal Health Updates Instructions for Presource Packs With BD Alaris Infusion SetsCAH · newsroomamerica.com · 20 Oct 2026Labcorp To Buy Myriad Genetics' Prenatal Testing Business For $210 MlnLH · finanzen.ch · 20 Oct 2026Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35%LH · rttnews.com · 15 Oct 2026
0 headlines in the last 90 days name David P. King; 6 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.